UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 1-SA
x SEMIANNUAL REPORT PURSUANT TO REGULATION A
or
¨ SPECIAL FINANCIAL REPORT PURSUANT TO REGULATION A
For the fiscal semiannual period ended: June 30, 2021
TriplePulse, Inc.
(Exact name of registrant as specified in its charter)
Delaware | 46-1514058 | |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
3103 Neilson Way, Suite D
Santa Monica, CA 90405
(Mailing Address of principal executive offices)
(650) 241-8372
Issuer’s telephone number, including area code
In this report, the terms “our,” “we,” “us” or “the company” refers to TriplePulse, Inc.
This report may contain forward-looking statements and information relating to, among other things, the company, its business plan and strategy, and its industry. These forward-looking statements are based on the beliefs of, assumptions made by, and information currently available to the company’s management. When used in this report, the words “estimate,” “project,” “believe,” “anticipate,” “intend,” “expect” and similar expressions are intended to identify forward-looking statements, which constitute forward looking statements. These statements reflect management’s current views with respect to future events and are subject to risks and uncertainties that could cause the company’s actual results to differ materially from those contained in the forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made. The company does not undertake any obligation to revise or update these forward-looking statements to reflect events or circumstances after such date or to reflect the occurrence.
Item 1. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion of our financial condition and results of operations should be read in conjunction with our financial statements and the related notes included in this report. The following discussion contains forward-looking statements that reflect our plans, estimates, and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Unless otherwise indicated, the latest results discussed below are as of June 30, 2021.
1
The following discussion of our financial condition and results of operations for the six month period ended June 30, 2021, compared to the same period in 2020. This discussion should be read in conjunction with our consolidated financial statements and the related notes.
Overview
The Company produces and sells high function food, beverage, and nutrition products to mainstream consumers that deliver meaningful and measurable outcomes. We believe that consumers consider our brand, TruBrain, as one of the most premium, trusted brands in cognitive performance - one that produces positive results for consumers and can be measured by biomarkers. Aside from superior products, we believe that our brand reputation sets us apart from the competition. Our direct-to-consumer (“DTC”) channel consists of online subscription sales of products produced by the Company.
We seek to reach our target customer audience through a multi-faceted marketing strategy that is designed to integrate our brand image with the lifestyles we represent. We pursue a marketing strategy which leverages our fans, ambassadors, digital marketing and social media, and a variety of grassroots initiatives. We also plan to continue to explore how we can complement and amplify our community-based initiatives with brand-building activity. We are continuously looking to partner and build meaningful relationships with social media influencers to produce high-quality achievement-focused content. We believe this approach offers an opportunity for our customers to develop a strong identity with our brands and culture.
Results of Operations
Summary of Results of Operations for the Six months ended June 30, 2021 and 2020:
Net Revenues
Net revenues for the six months ended June 30, 2021 were $872,742, compared to $743,162 for the six months ended June 30, 2020, an increase of 17%. The increase in revenue was primarily due to increased new customer acquisition spend in response to increased consumer demand for our products, along with improved consumer retention.
Cost of Goods Sold
Our cost of goods sold for the six months ended June 30, 2021 was $352,860, compared to $365,663 the six months ended June 30, 2020, a decrease of 4%. The decrease in cost of goods sold is primarily related to improved product gross margins and increased sales of our higher margin product offerings. Our gross margin may in the future fluctuate from period to period based on a number of factors, including cost of purchased components, discounts and promotional activity, the mix of products, and services we sell and the mix of channels through which we sell our products. We have historically experienced that gross margin, by product, tends to increase over time as we realize cost efficiencies as a result of economies of scale and sourcing strategies. In addition, our ability to continue to reduce the cost of our products, decreasing return rates, and controlling shipping costs are critical to increasing our gross margin over the long-term.
Operating Expenses
Total operating expenses the six months ended June 30, 2021 was $552,402, compared to $477,900 the six months ended June 30, 2020, an increase of 17%.
Marketing and advertising costs represented $100,402 and $87,606, respectively, of total operating expenses, an increase of 15%. Advertising costs increased year-over-year, as we continue to spend behind our highest performing new customer acquisition strategies, while remaining efficient in digital media spend to attract the right loyal mix of customers.
2
Wage expenses represented $188,762 and $230,708 respectively, a decrease of 18%. This decrease is mostly attributed to our efficient investment in human capital to support our core direct-to-consumer (“DTC”) sales channel.
General and administrative expenses increased $103,652, or 80%, from $129,586 for the six months ended June 30, 2020 to $233,238 for the six months ended June 30, 2021, largely due to the increase in consulting and professional fees.
Interest expense was $45,478 for the six months ended June 30, 2021 compared to $42,604 for the six months ended June 30, 2021.
Net Income (Loss)
Our net loss for the six months ended June 30, 2021 was $47,998, compared to a net loss of $113,005 for the six months ended June 30, 2020, a decrease of $65,007. We believe our investments in process and operational discipline will set us up well for sustainable expansion in future years.
Liquidity and Capital Resources
As of June 30, 2021, our current cash and cash equivalents were $1,146,955, compared to $902,844 as of December 31, 2020. Net inventory as of June 30, 2021was $329,187. As of June 30, 2021, we had total liabilities in the amount of $1,598,064. We currently anticipate that cash flow from operations will continue to provide a significant source of our operating needs. We expect that our liquidity needs for the next twelve months will be met by continued use of operating cash flows, funds raised in a Regulation A Offering and funds raised in our Regulation CF Offering in which we raised gross proceeds of $1,066,396. We believe that we will be able to continue to operate our business for the foreseeable future. The Company’s independent auditors’ report includes an explanatory paragraph regarding the Company’s ability to continue as a going concern.
Debt
We currently have three outstanding three (3) convertible promissory notes in the aggregate principal amount of $850,000, which accrue interest at a rate of 5% per annum, and which were due in 2017 and are therefore, in default, and have been accruing default interest at a rate of 10% per annum. As of June 30, 2021, the total interest outstanding under the Convertible Promissory Notes was $ 428,973. Each of the Convertible Promissory Notes may automatically convert into shares per the Convertible Promissory Note agreements, which may require the consent of the Convertible Promissory Note holders. Upon a qualified financing, which is set to occur upon a bona fide sale of equity in minimum amount $1,500,000, which may require the consent of the Convertible Promissory Note holders, the outstanding principal and interest convert into that number of shares of the stock issued in the Qualified Financing (the "Qualified Financing Stock") and shares of Common Stock of the Company determined by dividing the Outstanding Amount by a conversion price equal to the lesser of (i) the price per share of the Qualified Financing Stock sold by the Company in the Qualified Financing, discounted by 20%, and (ii) the price determined by dividing a pre-money valuation of $4,000,000.00 by the number of outstanding shares of the Common Stock on a fully-diluted and as-converted basis immediately prior to the closing of the Qualified Financing (not including the Excluded Shares). Of those shares, the number of Qualified Financing Stock will equal (x) the Outstanding Amount, divided by (y) the price per share paid by the other investors purchasing the Qualified Financing Stock in the Qualified Financing. Any remaining shares will be Common Stock.
The Qualified Financing Stock delivered to the noteholder pursuant to such conversion shall have the same rights, preferences, privileges as the Qualified Financing Stock delivered to other investors in the Qualified Financing, and the noteholder shall enjoy the same contractual rights as other investors in the Qualified Financing. Therefore, if the notes are converted, the conversion will result in a dilution of your investment.
3
Loan Under the CARES Act
In April 2020, the Company applied for assistance via two programs being offered by the Small Business Administration in response to the COVID-19 crisis: the Paycheck Protection Program (“PPP”) Loan and the Economic Injury Disaster Loan (“EIDL”).
On April 15, 2020, the Company entered into a payroll protection loan with Coastal Community Bank, guaranteed by the U.S. Small Business Administration (SBA), due April 15, 2022 for $20,900, with an interest rate of 1%. This note had a due date of April 15, 2022, and also had the possibility of forgiveness. This note was forgiven on December 31, 2020 and the balance on this note and accrued interest as of December 31, 2020 was $0.
On July 8, 2020 the company entered into a loan with Coastal Community Bank, guaranteed by the U.S. Small Business Administration (SBA) in the amount of $150,000, with monthly payments beginning July 8, 2021 in the amount of $751 per month for a term of Thirty (30) years, with an interest rate of 3.75% per annum. At December 31, 2020 the outstanding balance on this note was $150,000.
On January 26, 2021, the Company entered into a payroll protection loan with Coastal Community Bank, guaranteed by the U.S. Small Business Administration (SBA), due April 15, 2022 for $40,600, with an interest rate of 1%. This note is due in full on January 26, 2023, and also has the possibility of forgiveness.
Trend Information
Our primary goal is to attract and retain loyal customers in our DTC sales channel. As we add customers we will be able to grow our brand. Sales trends for the year ended December 31, 2020 showed strong demand across all of TruBrain's Offerings. We continue to find media channels to advertise our products and acquire new customers. We’ve been able to organically increase our wholesale sales channel, led by Erewhon.
The cognitive nutrition industry is a sizable market in the United States. We believe TruBrain is one of the few cognitive nutrition brands that is connecting with the discerning and savvy consumers and that should lead to a significant and expanding market opportunity.
Although it is extremely difficult to predict what the industry will experience after the COVID-19 pandemic, we feel that there will be opportunities for companies like ours to take advantage of new consumer trends, habits, and industry needs that evolve because of this pandemic. We have developed preparedness plans to help protect the safety of our employees, while safely continuing business operations. We have worked with our manufacturing, logistics and other supply chain partners to build communication and monitoring processes for all aspects of our product and delivery supply chain.
COVID-19
In March 2020, the World Health Organization declared the outbreak of COVID-19 as a pandemic, which continues to spread throughout the globe. The impacts of the outbreak are unknown and continue to evolve. A widespread health crisis has adversely affected and could continue to affect the global economy, resulting in an economic downturn that could negatively impact the value of the Company’s shares and investor demand for shares generally.
The continued spread of COVID-19 has also led to severe disruption and volatility in the global capital markets, which could increase our cost of capital and adversely affect our ability to access the capital markets in the future. It is possible that the continued spread of COVID-19 could cause a further economic slowdown or recession or cause other unpredictable events, each of which could adversely affect our business, results of operations or financial condition.
COVID-19 has been a highly disruptive economic and societal event that has affected our business and has had a significant impact on consumer shopping behavior. To serve our customers while also providing for the safety of our team members, we have adapted aspects of our logistics, transportation, supply chain and purchasing processes.
4
In Fiscal 2020, we experienced a decrease in demand for our products, as a result of changes to consumer behaviors resulting from the various stay-at-home and restaurant restriction orders and other restrictions placed on consumers throughout much of the United States in response to the COVID-19 pandemic. This resulted in lower revenue, notably in the months of March, April, and May 2020. This revenue reduction has since returned to pre-COVID-19 levels. Although revenue has seemed to have recovered in the short term, we cannot predict the duration or severity of the economic impact of COVID-19 or its ultimate impact on our operations.
The ultimate financial impact on the Company’s future operating results and consolidated financial statements cannot be reasonably estimated at this time. However, as of the date of this Offering Circular, the company has experienced renewed demand for its products so it does not expect this matter will have a material negative impact on its business, results of operations, and financial position.
Item 2. Other Information
None.
Item 3. Financial Statements
TriplePulse, Inc.
dba TruBrain
Balance Sheets (unaudited)
June 30, 2021 | December 31, 2020 | |||||||
Assets | ||||||||
Current assets | ||||||||
Cash and cash equivalents | $ | 1,146,955 | $ | 902,844 | ||||
Inventories | 329,187 | 333,352 | ||||||
Other current assets | - | - | ||||||
Total current assets | 1,476,142 | 1,236,196 | ||||||
Total assets | $ | 1,476,142 | $ | 1,236,196 | ||||
Liabilities and stockholders’ equity | ||||||||
Current liabilities: | ||||||||
Accounts payable and accrued expenses | $ | 51,362 | $ | 59,433 | ||||
Accrued interest | 92,782 | 81,054 | ||||||
Accrued interest, related party | 341,750 | 308,000 | ||||||
Deferred revenue | 71,570 | 34,531 | ||||||
PPP Loan | 40,600 | - | ||||||
Current portions of SBA notes payable | 12,427 | 3,655 | ||||||
Related party convertible notes payable | 675,000 | 675,000 | ||||||
Convertible notes payable | 175,000 | 175,000 | ||||||
Total current liabilities | 1,460,491 | 1,336,673 | ||||||
Long term liabilities | ||||||||
SBA note payable | 137,573 | 146,345 | ||||||
Total longterm liabilities | 137,573 | 146,345 | ||||||
Total liabilities | 1,598,064 | 1,483,018 | ||||||
Commitments and contingent liabilities | - | - | ||||||
Stockholders’ deficit | ||||||||
Preferred stock Series A, 66,666 authorized, par value $0.0001, and 66,666 shares issued and outstanding at June 30, 2021 and December 31, 2020 respectively | 7 | 7 | ||||||
Preferred stock Series B, 43,750 authorized, par value $0.0001, and 41,667 shares issued and outstanding at June 30, 2021 and December 31, 2020 respectively | 4 | 4 | ||||||
Common Stock, 100,000,000 authorized, par value $0.0001, and 45,333,582 and 45,333,852 shares issued and outstanding at June 30, 2021 and December 31, 2020 respectively | 4,638 | 4,533 | ||||||
Additional paid-in capital | 1,749,755 | 1,555,122 | ||||||
Subscription Receivable | (21,840 | ) | - | |||||
Accumulated deficit | (1,854,486 | ) | (1,806,488 | ) | ||||
Total stockholders’ equity | (121,922 | ) | (246,822 | ) | ||||
Total liabilities and stockholders’ equity | $ | 1,476,142 | $ | 1,236,196 |
The accompanying notes are an integral part of these financial statements
5
TriplePulse, Inc. | ||||||||
dba TruBrain | ||||||||
Statements of operations | ||||||||
For the six months ended June 30 (unaudited) | ||||||||
2021 | 2020 | |||||||
Revenue | $ | 872,742 | $ | 743,162 | ||||
Cost of goods sold | 352,860 | 365,663 | ||||||
Gross profit | 519,882 | 377,499 | ||||||
Selling, general, and administrative expenses | ||||||||
Marketing and advertising | 100,402 | 87,606 | ||||||
Wages | 188,762 | 230,708 | ||||||
General and administrative expenses | 233,238 | 129,586 | ||||||
Total Expenses | 522,402 | 447,900 | ||||||
Income (loss) from operations | (2,520 | ) | (70,401 | ) | ||||
Other income (expenses) | ||||||||
Interest expense | (45,478 | ) | (42,604 | ) | ||||
Total other income (expenses) | (45,478 | ) | (42,604 | ) | ||||
Income (loss) before taxes | (47,998 | ) | (113,005 | ) | ||||
Provision for income taxes | - | - | ||||||
Net Income (loss) | $ | (47,998 | ) | $ | (113,005 | ) | ||
Net Income (loss) per share - basic | $ | (0.00 | ) | $ | (0.00 | ) | ||
Weighted average number of common shares outstanding - basic | 45,510,578 | 45,205,882 | ||||||
Net Income (loss) per share - diluted | $ | (0.00 | ) | $ | (0.00 | ) | ||
Weighted average number of common shares outstanding - diluted | 45,510,578 | 45,205,882 |
The accompanying notes are an integral part of these financial statements
6
TriplePulse, Inc.
dba TruBrain
Statements of changes in stockholders' equity
For the six months ended June 30, 2019
(unaudited)
Preferred Stock | Common Stock | Total | ||||||||||||||||||||||||||||||||||||||
Series A | Series B | Additional | ||||||||||||||||||||||||||||||||||||||
Shares | Amount | Shares | Amount | Shares | Amount | Paid-in Capital | Subscriptions Receivable | Accumulated Deficit | Stockholders' Equity | |||||||||||||||||||||||||||||||
Balance on December 31, 2019 | 66,667 | $ | 7 | 41,667 | $ | 4 | 45,032,956 | $ | 4,504 | $ | 1,626,439 | $ | (136,778 | ) | $ | (1,735,996 | ) | $ | (241,820 | ) | ||||||||||||||||||||
Common stock issued for cash | - | - | - | - | 238,065 | 24 | 78,536 | - | - | 78,559 | ||||||||||||||||||||||||||||||
offering cost | - | - | - | - | - | - | (30,000 | ) | - | (30,000 | ) | |||||||||||||||||||||||||||||
Net income | - | - | - | - | - | - | - | (113,005 | ) | (113,005 | ) | |||||||||||||||||||||||||||||
Balance on June 30, 2020 | 66,667 | $ | 7 | 41,667 | $ | 4 | 45,271,021 | $ | 4,527 | $ | 1,674,975 | $ | (136,778 | ) | $ | (1,849,001 | ) | $ | (306,266 | ) |
The accompanying notes are an integral part of these financial statements
7
TriplePulse, Inc. dba TruBrain
Statements of changes in stockholders' equity
For the six months ended June 30, 2021 (unaudited)
Preferred Stock | Common Stock | Total | ||||||||||||||||||||||||||||||||||||||
Series A | Series B | Additional | ||||||||||||||||||||||||||||||||||||||
Shares | Amount | Shares | Amount | Shares | Amount | Paid-in Capital | Subscriptions Receivable | Accumulated Deficit | Stockholders' Equity | |||||||||||||||||||||||||||||||
Balance on December 31, 2020 | 66,666 | $ | 7 | 41,667 | $ | 4 | 45,333,582 | $ | 4,533 | $ | 1,555,122 | $ | - | $ | (1,806,488 | ) | $ | (246,822 | ) | |||||||||||||||||||||
Common stock issued for cash | 1,047,783 | 105 | 377,099 | (21,840 | ) | - | 355,364 | |||||||||||||||||||||||||||||||||
Offering Cost | (182,466 | ) | (182,466 | ) | ||||||||||||||||||||||||||||||||||||
Net income | - | - | - | - | - | - | - | (47,998 | ) | (47,998 | ) | |||||||||||||||||||||||||||||
Balance on June 30, 2021 | 66,666 | $ | 7 | 41,667 | $ | 4 | 46,381,365 | $ | 4,638 | $ | 1,749,755 | $ | (21,480 | ) | $ | (1,854,486 | ) | $ | (121,922 | ) |
The accompanying notes are an integral part of these financial statements
8
TriplePulse, Inc.
dba TruBrain
Statements of Cash Flows
For the six months ended June 30, (unaudited)
�� | 2021 | 2020 | ||||||
Cash flows from operating activities: | ||||||||
Net Income (loss) | $ | (47,998 | ) | $ | (113,005 | ) | ||
Adjustments to reconcile net income (loss) to net | ||||||||
cash provided by (used in) operating activities: | ||||||||
Inventory obsolescence impairment | - | 6,700 | ||||||
Changes in operating assets and liabilities: | ||||||||
Inventory | 4,165 | (217,809 | ) | |||||
Other current assets | - | - | ||||||
Accounts payable and accrued expenses | (8,071 | ) | 112,979 | |||||
Deferred revenue | 37,039 | 10,852 | ||||||
Accrued interest | 11,728 | 8,854 | ||||||
Accrued interest related party | 33,750 | 33,750 | ||||||
Net cash provided by (used in) operating activities | 30,613 | (157,679 | ) | |||||
Cash flows from financing activities: | ||||||||
Payments of fund raising costs | (182,466 | ) | (30,000 | ) | ||||
Proceeds from issuance of common stock | 355,364 | 78,559 | ||||||
Proceeds from notes payable | 40,600 | 20,900 | ||||||
Net cash provided by financing activities | 213,498 | 69,459 | ||||||
Cash and cash equivalents and restricted cash: | ||||||||
Net change during the period | 244,111 | (88,220 | ) | |||||
Balance, beginning of period | 902,844 | 783,147 | ||||||
Cash and cash equivalents, ending | $ | 1,146,955 | $ | 694,927 | ||||
Supplemental cash flow information: | ||||||||
Interest Paid | $ | - | $ | - | ||||
Income taxes paid | $ | - | $ | - |
The accompanying notes are an integral part of these financial statements
9
TriplePulse, Inc.
dba TruBrain
Notes to the Financial Statements
NOTE 1 – NATURE OF BUSINESS
TriplePulse, Inc. dba TruBrain (the “Company”) was incorporated on November 14, 2012 under the laws of the State of Delaware and is headquartered in Santa Monica, CA. The Company develops and produces special formulated brands of food and beverage to enhance brain function. The Company has marketed their products to consumers through an online platform.
NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The Company’s year-end is December 31.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Fair Value of Financial Instruments
Financial Accounting Standards Board (“FASB”) guidance specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). The three levels of the fair value hierarchy are as follows:
Level 1 - Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 1 primarily consists of financial instruments whose value is based on quoted market prices such as exchange-traded instruments and listed equities.
Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly (e.g., quoted prices of similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active).
Level 3 - Unobservable inputs for the asset or liability. Financial instruments are considered Level 3 when their fair values are determined using pricing models, discounted cash flows or similar techniques and at least one significant model assumption or input is unobservable.
The carrying amounts reported in the balance sheets approximate their fair value.
10
Cash and Cash Equivalents
The Company considers all highly liquid investments with an original maturity of 90 days or less to be cash equivalents. At December 31, 2020 and December 31, 2019, the Company had no items, other than bank deposits, that would be considered cash equivalents. The Company maintains its cash in bank deposit accounts, that may at times, exceed federal insured limits of $250,000. No losses have been recognized as a result of these excess amounts.
Inventory
Inventory is stated at the lower of cost or market value and is accounted for using the first-in-first-out method (“FIFO”). The Company analyzes inventory per any potential obsolescence, and records impairment and obsolescence reserve against inventory as deemed necessary and based on historical experience. As of June 30, 2021 and December 31, 2020 the Company had an impairment allowance of $17,922 and $17,922, respectively.
Revenue Recognition
During the year ended December 31, 2019, the Company adopted Accounting Standards Update (ASU) 2014-01, “Revenue from Contracts with Customers” which outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers (Accounting Standards Codification “ASC” Topic 606) and supersedes most current revenue recognition guidance (ASC Topic 605). ASC Topic 606 outlines the following five-step process for revenue recognition:
· Identification of the contract with a customer;
· Identification of the performance obligations in the contract;
· Determination of the transaction price;
· Allocation of the transaction price to the performance obligations in the contract; and
· Recognition of revenue when, or as, the Company satisfies the performance obligations.
The Company recognizes revenue when the performance obligations have been met, which is typically at the time of shipment. Return reserves are estimated based on historical experiences.
Deferred revenue consists of cash received from customers for purchase commitments that are monthly, quarterly, bi-annual and annual of the product sold on the Company’s website. Revenue from these purchases are deferred and recognized as the performance obligation is met. As of June 30, 2021, and December 31, 2020, the Company had $71,570 and $34,531in deferred revenue, respectively.
The adoption of ASU 606 did not have a material impact on our financial statements.
Advertising costs
The Company’s advertising costs are expensed as incurred. During the six months ended June 30, 2021 and 2020, the Company recognized $100,402 and $87,606 in advertising, respectively.
Stock-Based Compensation
During the year ended December 31, 2019, the Company adopted ASU 2018-07, Compensation – Stock Compensation (Topic 718) that accounts for non-employee awards in the same manner as employee awards. Under the fair value recognition provisions of ASC 718, stock-based compensation cost is measured at the grant date based on the fair value of the award and is recognized as expense ratably over the requisite service period, which is generally the option vesting period. The adoption of ASU 2018-07 did not have a material impact on our financial statements.
Stock Split
On September 11, 2019, the Board of Directors approved a 50:1 common stock split. Share and per share amounts for all periods presented in the accompanying financial statements and notes herein have been adjusted retroactively, where applicable, to reflect the stock split.
11
Convertible Debt
The Company evaluated the convertible debt under the guidelines established by ASC 470-20, Debt with Conversion and Other Options. ASC 470-20 governs the calculation of an embedded beneficial conversion and/or debt issued with warrants, which is treated as a discount to the instruments where derivative accounting does not apply.
Offering Costs
The Company accounts for offering costs in accordance with ASC 340, Other Assets and Deferred Costs. Prior to the completion of an offering, offering costs are capitalized as deferred offering costs on the balance sheet. The deferred offering costs are netted against the proceeds of the offering in stockholders’ deficit. If the offering is unsuccessful, such costs are expensed.
Preferred Stock
ASC 480, Distinguishing Liabilities from Equity, includes standards for how an issuer of equity classifies and measures on its balance sheet certain financial instruments with characteristics of both liabilities and equity. Management is required to determine the presentation for the preferred stock as a result of the redemption and conversion provisions in the agreement. Specifically, management is required to determine whether the embedded conversion feature in the preferred stock is clearly and closely related to the host instrument, and whether the bifurcation of the conversion feature is required, and the conversion feature should be accounted for as a derivative instrument. If the host instrument and conversion feature are determined to be clearly and closely related (both more akin to equity), derivative liability accounting under ASC 815, Derivatives and Hedging, is not required. Management determined that the host contract of the preferred stock is more akin to equity, and accordingly, liability accounting is not required by the Company. The Company has presented preferred stock within stockholders' deficit in the accompanying balance sheet.
Earnings per Common Share
Basic earnings per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net income (loss) by the weighted average number of common shares and dilutive potential common shares outstanding during the period. Diluted earnings per common shares includes the dilutive effect of the additional potential common shares issuable under convertible debt, stock options, warrants, and preferred shares as fully converted. For the six months ended years June 30, 2021 and 2020, dilutive shares include 461,350 common stock options and warrants, 2,083 Series Seed-B warrants which are convertible into 104,150 shares of common stock and preferred stock that is convertible into 5,416,700 shares of common stock, and 2,361,111 shares of common stock on an if-converted basis for outstanding convertible debt. For the six months ended June 30, 2021 and 2020, such dilutive securities were excluded as such were antidilutive. Earnings and dividends per share are restated for all stock splits through the date of issuance of the financial statements.
Research and Development Costs
Research and development costs are expensed as incurred. We incur research and development costs to improve and expand our product offerings, introduce new technologies to customers, and support our sales channels to generate consumer interest and engagement. These costs typically include components such as formulation, personnel related expenses, consulting expenses, prototype materials, market research, analytical laboratory testing, and user testing. For the six months ended June 30, 2021 and 2020, the Company recognized $1,292 and $5,843 in research and development costs, respectively, which have been in included in general and administrative costs in the accompanying statements of operations.
12
Shipping and Handling Costs
Shipping and handling costs are included in cost of goods sold and expensed as incurred. For the six months ended June 30, 2021 and 2020, the Company incurred $120,707 and $107,703 in shipping and handling costs, respectively.
Recent Accounting Pronouncements
In February 2016, the FASB issued ASU 2016-02, a new standard on the accounting for leases, which requires a lessee to record a right-of-use asset and a corresponding lease liability on the balance sheet for all leases with terms longer than twelve months. The standard also expands the required quantitative and qualitative disclosures surrounding leasing arrangements. The standard is effective for nonpublic companies for annual reporting periods beginning after December 15, 2021. The Company is in the process of evaluating the impact of ASU 2016-02 on the Company’s financial statements and disclosures.
In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326) which replaces incurred losses methodology with expected losses. The standard will require the Company to estimate any expected credit loss as it applies to financial assets and recognize an allowance for an expected credit loss. The standard will be effective in January 2023. The Company is currently in the process of evaluating the impact of ASU 2016-13 on the Company’s financial statements and disclosures.
In August 2020, the FASB issued ASU 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40); Accounting for Convertible Instruments and Contracts in an Entity’s own Equity. The standard will simplify the accounting for convertible debt with derivatives and hedging. The standard will be effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The Company is in the process of evaluating the impact of ASU 2020-06 on the Company’s financial statements and disclosures.
The FASB issues ASUs to amend the authoritative literature in ASC. There have been several ASUs to date, including those above, that amend the original text of ASC. Management believes that those issued to date either (i) provide supplemental guidance, (ii) are technical corrections, (iii) are not applicable to us, or (iv) are not expected to have a significant impact on our financial statements.
NOTE 3 – GOING CONCERN
The Company has incurred losses from inception of approximately $1.8 million, has historically suffered negative cash flows and has limited working capital, which raise substantial doubt about the Company's ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent upon management's plans to raise additional capital from the issuance of debt or the sale of stock, its ability to maintain profitable operations and cash flows. There are no assurances that management’s plans will be successful. The accompanying financial statements do not include any adjustments that might be required should the Company be unable to continue as a going concern.
In December 2019, a novel strain of coronavirus (COVID-19) was reported in Wuhan, China and has spread throughout the United States and the rest of the world. The World Health Organization has declared the outbreak to constitute a “Public Health Emergency of International Concern.” This contagious disease outbreak, which has not been contained, and is disrupting supply chains and affecting production and sales across a range of industries in United States and other companies as a result of quarantines, facility closures, and travel and logistics restrictions in connection with the outbreak, as well as the worldwide adverse effect to workforces, economies and financial markets, leading to a global economic downturn. Therefore, the Company expects this matter to negatively impact its operating results. However, the related financial impact and duration cannot be reasonably estimated at this time.
As the COVID-19 pandemic continues to drive global uncertainty and disruption, which has created headwinds for our business. Our ecommerce business continues to recover and perform sufficiently well in this challenging environment. To date, we have successfully navigated the business during the COVID-19 pandemic, managing our working capital effectively.
We have experienced some minor shipment delays from our suppliers; however, we have not encountered any major disruptions in our supply chain. We have been maintaining adequate safety stocks to support our growth and we currently have adequate inventory on hand to meet our current demands. Overall, we believe the supply chain disruptions arising from COVID-19 will not have a material impact to our business operations.
In response to the pandemic, we prioritized the health and safety of our team by enhancing safety protocols and we have been able to successfully conduct business virtually.
13
NOTE 4 – NOTES PAYABLE
On April 15, 2020, the Company entered into a payroll protection loan with Coastal Community Bank, guaranteed by the U.S. Small Business Administration (SBA), due April 15, 2022, for $20,900, with an interest rate of 1%. This note is due in full on April 15, 2022, and also has the possibility of forgiveness. This note was forgiven on December 31, 2020, and the balance on this note and accrued interest as of December 31, 2020 was $0.
On January 26, 2021, the Company entered into a payroll protection loan with Coastal Community Bank, guaranteed by the U.S. Small Business Administration (SBA), due April 15, 2022 for $40,600, with an interest rate of 1%. This note is due in full on January 26, 2023, and also has the possibility of forgiveness.
NOTE 5 – COMMITMENTS AND CONTINGENCIES
Except as may be set forth below, we are not a party to any legal proceedings, and we are not aware of any claims or actions pending or threatened against us. In the future, we might from time to time become involved in litigation relating to claims arising from our ordinary course of business, the resolution of which we do not anticipate would have a material adverse impact on our financial position, results of operations or cash flows.
Concentration
The Company uses one primary contract manufacturer and fulfillment center for its top revenue producing drink products. This represents concentrated risks for the main source of revenue for the Company. An adverse impact to one or both of these facilities and/or vendors would cause a material impact on the Company’s operations.
Lease
On June 1, 2020, the Company entered into a lease with a term of five (5) years commencing June 1, 2020. The Company has the option to extend the lease for one additional period of five (5) years upon the same terms and conditions of the Lease. Monthly base rent will range from $4,750 to $5,346 per month.
NOTE 6 – CONVERTIBLE DEBT
The Company issued convertible debt for cash proceeds of $1,455,000 in 2014 and 2015, of which $675,000 was with related parties. These securities are convertible into common stock of the Company, matured 24 months from the date of issuance, and contain a 5% stated rate of interest prior to maturity with 10% default interest after maturity. The convertible debt may be converted upon the following:
1. Automatic conversion - Upon a qualified financing, which is set to occur upon a bona fide sale of equity in minimum amount ranging from $500,000 to $1,500,000, which may require the consent of the Convertible Promissory Note holders, the outstanding principal and interest convert into that number of shares of the stock issued in the Qualified Financing (the "Qualified Financing Stock") and shares of Common Stock of the Company determined by dividing the Outstanding Amount by a conversion price equal to the lesser of (i) the price per share of the Qualified Financing Stock sold by the Company in the Qualified Financing, discounted by 20%, and (ii) the price determined by dividing a pre-money valuation of $4,000,000.00 by the number of outstanding shares of the Common Stock on a fully-diluted and as-converted basis immediately prior to the closing of the Qualified Financing (not including the Excluded Shares). Of those shares, the number of Qualified Financing Stock will equal (x) the Outstanding Amount, divided by (y) the price per share paid by the other investors purchasing the Qualified Financing Stock in the Qualified Financing. Any remaining shares will be Common Stock.
14
The Qualified Financing Stock delivered to Holder pursuant to such conversion shall have the same rights, preferences, privileges as the Qualified Financing Stock delivered to other investors in the Qualified Financing, and Holder shall enjoy the same contractual rights as other investors in the Qualified Financing.
2. Optional conversion - Upon no qualified financing or change of control transaction and outside maturity date, the holder may provide written notice to be delivered to the Company to convert the security into the number of shares of common stock by dividing the outstanding amount by a pre-money valuation of $4,000,000 by the number of outstanding shares of common stock on a fully-diluted and as converted basis.
3. Change of Control - Upon a change in control transaction, the Company shall redeem the Notes at the election of the purchaser for an amount equal to a) 100-200% of the outstanding amount (depending on the terms of the individual note), or b) the consideration which the holder would have received in the change in control transaction (to be paid in the same form of consideration) had the holder converted outstanding principal and interest into shares of common stock of the Company at a conversion price per share determined by dividing a pre-money valuation of $4,000,000 by the number of outstanding shares of common stock on a fully-dilutive basis.
In 2019, the qualified financing thresholds of $500,000 and $750,000 were triggered, and therefore, convertible notes including interest thereon totaling $844,896, converted into 2,293,605 shares of common stock.
For the six months ended June 30, 2021 and 2020, the Company recognized interest expense on the convertible notes of $33,750 and $42,604, respectively.
NOTE 7 – STOCKHOLDERS’ DEFICIT
Common Stock
The Company is authorized to issue 100,000,000 shares of common stock, $0.0001 par value per share.
During the year that ended December 31, 2019, the Company sold 2,822,801 shares of Common Stock for gross proceeds of $966,844, of which $136,778 is receivable as of December 31, 2019. Net proceeds received through December 31, 2019 totaled $830,066. The Company also incurred $326,892 in offerings costs for this offering.
During 2019, the Company had convertible notes which automatically converted into common stock; see Note 6 for further discussion.
On September 11, 2019 the Board of Directors approved a 50:1 stock split by filing a certificate of amendment to its amended and restated certificate of incorporation with the Secretary of State of the State of Delaware. The Company did not timely file an Amendment to the Certificate of Incorporation of the Company to affect the stock split and specify the number of shares of common stock of the Company that the Company was authorized to issue. To correct these defective corporate acts pursuant to Delaware General Corporation Law Section 204, the Board filed a Certificate of Designation with the Delaware Secretary of State dated January 29, 2020, pursuant to which the Company ratified the stock split and the number of authorized shares of common stock of the Company, with an effective date of September 11, 2019. Accordingly, all share and per share amounts for all periods presented in the accompanying financial statements and notes thereto have been adjusted retroactively, where applicable, to reflect the stock split.
During the years ended December 31, 2020, the Company sold 300,626 shares of Common Stock for gross proceeds of $66,029 and received $136,778 in subscriptions receivable. The Company also incurred $129,863 in offerings costs for this offering, which resulted in net proceeds of $72,974.
During the six months ended June 30, 2021, the Company sold 1,047,783 shares of Common Stock for gross proceeds of $355,364 and received $21,840 in subscriptions receivable. The Company also incurred $182,466 in offerings costs for this offering, which resulted in net proceeds of $172,793.
15
Preferred Stock
The Company is authorized to issue 66,667 shares of Series A Preferred Stock, $0.0001 par value and 41,667 shares of Series B Preferred stock, $0.0001 par value; collectively referred to as the “Preferred Stock”.
Conversion rights – The holders of Preferred Stock have the following conversion rights:
Each share of Preferred Stock is convertible, at any time, at the option of the holder thereof, into such number of fully paid and non-assessable shares of Common Stock as is determined by dividing the Initial Issue Price of the Preferred Stock (as appropriately adjusted for stock splits, stock dividends, recapitalizations and the like) by the then applicable Conversion Price for a share of Preferred Stock. The Initial Issue Price per share of Series Seed Preferred Stock is $0.30 per share, and of Series Seed-B Preferred Stock $0.60 per share. Due to the stock-split noted above, each share of preferred stock is convertible into 50 shares of common stock.
Each share of Preferred Stock shall automatically be converted into Common Stock immediately upon the earlier of (a) the closing of a firm commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933, as amended, or (ii) the date, time, or occurrence of an event specified by written consent or agreement of the holders of at least a majority of the then outstanding shares of Preferred Stock, voting together as a single class.
Additional Financing Rights: – In the event the Company issues securities in its subsequent equity financings which have (a) rights, preferences or privileges that are more favorable than the terms of Investor, such as price based anti-dilution protection, or (b) provides all such future investors other contractual terms such as preemptive rights or registration rights, the Company shall provide substantially equivalent rights to Investor.
Liquidation rights – Upon a liquidation, dissolution or winding up of the corporation, or deemed liquidation event, the holders of our Series Seed Preferred Stock and Series Seed-B Preferred Stock, are entitled to receive the greater of the a) Initial Issue price plus any declared and unpaid dividends, or b) such amount per share as would have been payable had preferred stock been converted into common stock immediately before such event, in distributions, before any funds are distributed to the holders of common stock. As of the date hereof, upon a Liquidation Event, the holders of outstanding preferred stock would be entitled to receive the first $45,000 in distributions as stated in agreements, with the remaining amounts being split pro rata amongst the holders of common stock.
Voting rights – The holders of preferred stock shall have the right to one vote for each share of common stock into which such preferred stock could then be converted with the same voting rights and powers of common shareholders, except with respect to the election of directors. As long as there are any shares of preferred stock outstanding, we may not, do any of the following without the vote of the holders of a majority of the outstanding shares of preferred stock, voting together as a single class: (1) alter or change the rights, powers or privileges of the preferred stock as set forth in our Certificate of Incorporation, in any way that adversely affects the preferred stock, (2) increase or decrease the authorized number of shares of preferred stock (or any series thereof), (3) authorize or create any new class or series of capital stock having rights, powers or privileges that are senior to any series of preferred stock, (4) redeem or repurchase any shares of common stock or preferred stock (other than pursuant to employee or consulting agreements giving us the right to repurchase such share at the original cost thereof upon termination of services, or (5) declare or pay any dividend or otherwise make a distribution to the holders of preferred stock or common stock. Therefore, the holders of our preferred stock, may prevent us from taking certain corporate actions, that our board of directors may be in the best interests of the holders of our common stock. See “Securities Being Offered – Certificate of Incorporation – Voting Rights.”
Dividend Rights – All dividends shall be declared pro rata on the shares of Common Stock and Preferred Stock, on a pari passu basis according to the number of shares of Common Stock held by such holders, or, in the case of Preferred Stock, the number of shares of Common Stock, into which such shares of Preferred Stock are convertible as of the record date for the payment of such dividends.
Other Rights of Holders of Preferred Stock – We are party to an Investors’ Rights Agreement with StartEngine Fund I, L.P., the holder of our Series Seed Preferred Stock, pursuant to which, in addition to holding certain information rights, StartEngine has a right of first refusal to purchase a specified portion of any new securities we may sell in the future.
16
Stock Options
In 2014, the Board of Directors adopted the TriplePulse, Inc. 2014 Incentive Plan (the “2014 Plan”). The 2014 Plan provides for the grant of equity awards to purchase shares of common stock. Up to 14,250,000 shares of common stock may be issued pursuant to awards granted under the 2014 Plan. The 2014 Plan is administered by the Board of Directors, and expires ten years after adoption, unless terminated earlier by the Board.
The Company has 7,908,197 shares issued and 6,341,803 shares remaining for issuance under the 2014 stock plan.
There were no grants or forfeitures during the six months ended June 30, 2021.
Warrants
The Company had outstanding warrants for the purchase of 2,083 and 211,350 shares of Series Seed-B preferred and
Warrants outstanding are fully vested. The Series Seed-B warrants can convert into 104,150 shares of common stock.
There were no grants or forfeitures during the six months ended June 30, 2021.
NOTE 7 – SUBSEQUENT EVENTS
In accordance with ASC 855, the Company has analyzed its operations subsequent to December 31, 2020 through the date these financial statements were issued and has determined that it does not have any other material subsequent events to disclose in these financial statements.
Item 4. Exhibits
The documents listed in the Exhibit Index of this report are incorporated by reference or are filed with this report, in each case as indicated below.
17
8.1 | Escrow Services Agreement* |
*Previously filed as an exhibit to the TriplePulse, Inc. Regulation A Offering Statement on Form 1-A and incorporated herein by reference.
18
SIGNATURES
Pursuant to the requirements of Regulation A, the issuer has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Santa Monica, California, on September 27, 2021.
TriplePulse, Inc. | ||
/s/ Christopher Thompson | ||
By Christopher Thompson, Chief Executive Officer | ||
Date: September 28, 2021 |
Pursuant to the requirements of Regulation A, this report has been signed below by the following persons on behalf of the issuer and in the capacities and on the date indicated.
By: | /s/ Christopher Thompson | |
Christopher Thompson | ||
Chief Executive Officer, Director Date: September 28, 2021 | ||
By: | /s/ Arif Fazal | |
Arif Fazal, Director Date: September 28, 2021 | ||
By: | /s/ Josh Payne | |
Josh Payne, Director Date: September 28, 2021 | ||
By: | /s/ Seth DeGroot | |
Seth DeGroot, Director Date: September 28, 2021 |
By: | /s/ Sheree Shelton | |
Sheree Shelton, Director Date: September 28, 2021 |
19